Versican CLIA Kit

Produktnummer ABIN6208406

Produktdetails Versican CLIA Kit

Target: Versican (Vcan)

Reaktivität: Maus

Nachweismethode: Chemiluminescent

Methodentyp: Sandwich ELISA

Detektionsbereich: 0.156 ng/mL - 10 ng/mL

Untere Nachweisgrenze: 0.156 ng/mL

Applikation: ELISA

Verwendungszweck: Mouse Versican (VS) CLIA Kit is a Sandwich CLIA Kit for use with Serum, plasma, tissue homogenates and other biological fluids.

Proben: Plasma, Serum, Tissue Homogenate

Analytische Methode: Quantitative

Sensitivität: < 0.066 ng/mL

Anwendungsinformationen

Applikationshinweise:

Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

Standard Form: Lyophilized

Plattentyp: Pre-coated

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Upon receipt, store the kit according to the storage instruction in the kit's manual.

Haltbarkeit: 6 months

Antigendetails

Target: Versican (Vcan)

Andere Bezeichnung: Versican (VS) (Vcan Produkte)

Synonyme: br146 CLIA Kit, cspg2 CLIA Kit, cspg2a CLIA Kit, sb:cb63 CLIA Kit, versican CLIA Kit, CSPG2 CLIA Kit, Cspg2 CLIA Kit, wgn CLIA Kit, ervr CLIA Kit, pg-m CLIA Kit, wgn1 CLIA Kit, Xversican CLIA Kit, dcan CLIA Kit, cspg2b CLIA Kit, fb99b07 CLIA Kit, wu:fb99b07 CLIA Kit, ERVR CLIA Kit, GHAP CLIA Kit, PG-M CLIA Kit, WGN CLIA Kit, WGN1 CLIA Kit, 5430420N07Rik CLIA Kit, 9430051N09 CLIA Kit, DPEAAE CLIA Kit, NG2 CLIA Kit, PG-M(V0) CLIA Kit, PG-M(V1) CLIA Kit, hdf CLIA Kit, versican a CLIA Kit, versican CLIA Kit, versican b CLIA Kit, vcana CLIA Kit, VCAN CLIA Kit, Vcan CLIA Kit, vcan CLIA Kit, vcanb CLIA Kit

Pathways: Glycosaminoglycan Metabolic Process